Citation Impact
Citing Papers
Acromegaly
2006 Standout
Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine
1995 Standout
Morbidity after Long-Term Remission for Acromegaly: Persisting Joint-Related Complaints Cause Reduced Quality of Life
2005
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
1995 Standout
Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts Type II diabetes independent of insulin resistance
2000
Critical periods in childhood for the development of obesity
1994
Dynamics of fat cell turnover in humans
2008 StandoutNature
Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis
1997
Combination Chemotherapy in Refractory Immune Thrombocytopenic Purpura
1993
Management of patients with chronic, refractory idiopathic thrombocytopenic purpura
2000
Comparison of Insulin Regimens in Patients with Non-Insulin-Dependent Diabetes Mellitus
1992
Quantitation of Muscle Glycogen Synthesis in Normal Subjects and Subjects with Non-Insulin-Dependent Diabetes by13C Nuclear Magnetic Resonance Spectroscopy
1990
The metabolic syndrome
2010 Standout
‘Metabolically healthy obesity’: Origins and implications
2012
Nonalcoholic Fatty Liver Disease
2002 Standout
Long-Term Morbidity and Mortality of Overweight Adolescents
1992 Standout
Guillain-Barré syndrome
2016 Standout
Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery
2004 Standout
The Implication of Somatotroph Adenoma Phenotype to Somatostatin Analog Responsiveness in Acromegaly
2005
Hormonal and Metabolic Effects of Radiotherapy in Acromegaly: Long-Term Results in 128 Patients Followed in a Single Center
2000
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Immunthrombocytopenic purpura as a model for pathogenesis and treatment of autoimmunity
1995
Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura
2000
Relation of Body Weight Change to Changes in Atherogenic Traits. A Study of Middle-Aged Japanese Obese Male Office Workers.
2000
Inflammation and insulin resistance
2006 Standout
Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels.
1994
Adverse Effects of Intravenous Immunoglobulin Therapy in 56 Patients with Autoimmune Diseases
2001
Platelet‐reactive IgG antibodies cloned by phage display and panning with IVIG from three patients with autoimmune thrombocytopenia
1999
Elevated incidence of sleep apnoea in acromegaly—correlation to disease activity
2012
Effect of Age on Excess Mortality in Obesity
1999
Pregnancy in acromegaly: experience from two referral centers and systematic review of the literature
2011
Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories
2013 Standout
Diabetes in Asia
2009 Standout
The metabolic syndrome
2005 Standout
Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes Mellitus<SUBTITLE>Progressive Requirement for Multiple Therapies (UKPDS 49)</SUBTITLE>
1999 Standout
Chronic Idiopathic Thrombocytopenic Purpura
1994
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Immune Thrombocytopenic Purpura
2002 Standout
Oral Magnesium Supplementation Improves the Metabolic Profile of Metabolically Obese, Normal-weight Individuals: A Randomized Double-blind Placebo-controlled Trial
2014
Hypercortisolism and Obesity
1995
Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements
1989
Exercise-based rehabilitation for coronary heart disease
2001
Laparoscopic splenectomy in chronic idiopathic thrombocytopenic purpura
2000
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
Resistance to Activated Protein C as a Basis for Venous Thrombosis
1994 Standout
Characterization of autoantibodies against the platelet glycoprotein antigens llb/llla in childhood idiopathic thrombocytopenia purpura
1995
Increased Fat Intake, Impaired Fat Oxidation, and Failure of Fat Cell Proliferation Result in Ectopic Fat Storage, Insulin Resistance, and Type 2 Diabetes Mellitus
2002
Subcutaneous adipocyte size and body fat distribution
2008
Exercise and Obesity
1993
Obesity as a medical problem
2000 StandoutNature
The Lipid Accumulation Product and All‐cause Mortality in Patients at High Cardiovascular Risk: A PreCIS Database Study
2009
Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under‐recognized and under‐diagnosed
2009
Multiple Sclerosis
2000 Standout
Association of Weight Status With Mortality in Adults With Incident Diabetes
2012
A Potential Decline in Life Expectancy in the United States in the 21st Century
2005 Standout
What We Talk About When We Talk About Fat
2014 Standout
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
Exercise during intermittent cold exposure prevents acclimation to cold rats.
1987
Advances in the diagnosis of idiopathic thrombocytopenic purpura
2000
Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study
2001 Standout
Acromegaly Caused by Secretion of Growth Hormone by a Non-Hodgkin's Lymphoma
2000
Exercise-based cardiac rehabilitation for coronary heart disease
2011 Standout
Recurrent miscarriage
2006 Standout
The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension
1989
Atherosclerosis
2000 StandoutNature
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Adipose tissue remodeling and obesity
2011
Platelet autoantibodies in patients with chronic liver disease
1995
Glucose Homeostasis and Safety in Patients with Acromegaly Converted from Long-Acting Octreotide to Pegvisomant
2005
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
Long-Term observation of 208 adults with chronic idiopathic thrombocytopenic purpura
1995
Visceral Obesity: A “Civilization Syndrome”
1993
Changes in Energy Expenditure Resulting from Altered Body Weight
1995 Standout
Association between Multiple Cardiovascular Risk Factors and Atherosclerosis in Children and Young Adults
1998 Standout
Body Fat Distribution and Insulin Resistance in Healthy Asian Indians and Caucasians
2001
Insulin Pharmacology
1988
A prospective study of protein‐specific assays used to investigate idiopathic thrombocytopenic purpura
1999
The effect of aging on carbohydrate metabolism: A review of the English literature and a practical approach to the diagnosis of diabetes mellitus in the elderly
1979
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Weight and Hypertension
1983
High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura
1991
Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis.
1992 StandoutNobel
Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
1998 Standout
Increased Insulin Sensitivity and Insulin Binding to Monocytes after Physical Training
1979
Effects of Weight Reduction on Obesity STUDIES OF LIPID AND CARBOHYDRATE METABOLISM IN NORMAL AND HYPERLIPOPROTEINEMIC SUBJECTS
1974
Effects of age, sex, and clinical conditions on adipose tissue cellularity in man
1974
Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study
2001
Insulin Resistance in Essential Hypertension
1987 Standout
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Characterization of autoantigenic epitopes on platelet glycoprotein IIb/IIIa using random peptide libraries
1996
Obesity: adverse effects on health and longevity
1979
Adipose tissue fat cell size and number in relation to metabolism in randomly selected middle-aged men and women
1971
Pregnancy-associated thrombocytopenia: pathogenesis and management
1992
Guillain-Barr� syndrome and chronic inflammatory demyelinating polyneuropathy: Immune mechanisms and update on current therapies
1995
Metabolic and health complications of obesity.
1990
A Transgenic Model of Visceral Obesity and the Metabolic Syndrome
2001 StandoutScience
Recombinant human natural autoantibodies against GPIIb/IIIa inhibit binding of autoantibodies from patients with AITP
1998
Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution.
1983
Brown Adipose Tissue: Function and Physiological Significance
2004 Standout
Site of enhanced insulin sensitivity in exercise-trained rats at rest
1980
Impact of Body Mass Index and the Metabolic Syndrome on the Risk of Cardiovascular Disease and Death in Middle-Aged Men
2009
Activation and Differentiation of Autoreactive B-1 Cells by Interleukin 10 Induce Autoimmune Hemolytic Anemia in Fas-deficient Antierythrocyte Immunoglobulin Transgenic Mice
2002 StandoutNobel
Pharmacologic Therapy for Type 2 Diabetes Mellitus
1999
Risk factors for myocardial infarction and death due to ischemic heart disease and other causes
1975
Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome
2000 Standout
ADIPOSE-CELL SIZE AND IMMUNOREACTIVE INSULIN LEVELS IN OBESE AND NORMAL-WEIGHT ADULTS
1972
Prospective evaluation of the clinical usefulness of an antigen- specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias
1996
Reappraisal of the role of insulin in hypertriglyceridemia
1974
IV immunoglobulin reduces circulating proinflammatory cytokines in Guillain-Barre syndrome
1999
The metabolically obese, normal-weight individual revisited.
1998
Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity
1996
Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura
1994
Hypertension in acromegaly and in the normal population: prevalence and determinants
2005
Effects of Endurance Training on Glucose Tolerance and Plasma Lipid Levels in Older Men and Women
1984
The Effect of Growth Hormone on Glucose Metabolism and Insulin Secretion in Man*
1982
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects.
1980
(D) Routes of delivery: Case studies
1992
Exercise, Glucose Transport, and Insulin Sensitivity
1998
Delayed Menarche and Amenorrhea in Ballet Dancers
1980 Standout
Role of Insulin Resistance in Human Disease
1988 Standout
Experience with protein A-immunoadsorption in treatment-resistant adult immune thrombocytopenic purpura
1992
Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura
2001
Physical training and insulin sensitivity
1986
Metabolic Syndrome in Normal-Weight Americans
2004
Diabetes and cardiovascular disease. The Framingham study
1979 Standout
Metabolic and Body Composition Factors in Subgroups of Obesity: What Do We Know?
2004
Effect of age on plasma triglyceride concentrations in man
1980
Inhaled insulin1Abbreviations: DM, diabetes mellitus; AIDs, acquired immune deficiency syndrome; SC, subcutaneous; DCCT, Diabetes Control and Complications Trial; IDDM, insulin-dependent diabetes mellitus; NIDDM, non-insulin-dependent diabetes mellitus; i.v., intravenous; DDPC, di-decanoyl-alpha-phosphatidylcholine; AUC, area under the curve; INH, inhaled; Cmax, maximum serum concentration; Cmin, minimum serum concentration; Tmax, time of maximum serum concentration; NS, not significant; HbA1c, hemoglobin A1c; OA, oral agent; SD, standard deviation; MDI, metered dose inhaler; DPI, dry powder inhaler; MMAD, mass median aerodynamic diameter; CMC, critical micelle concentration; SR, sustained release; PLGA, poly lactic acid-co-glycolic acid; GI, gastrointestinal, GSD, geometric standard deviation; TLC, total lung capacity; VC, vital capacity; SMK, smokers; MW, molecular weight; MP, melting point.1
1999
Direct detection of activated protein C in blood from human subjects
1992
Human Aging: Usual and Successful
1987 StandoutScience
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
2002 Standout
The molecular immunology of human platelet proteins
1992
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly-2011 Update
2011
Rapid measurement of free amino acids in serum and CSF using high-performance liquid chromatography
1981
Works of Peter Berchtold being referenced
Plasma autoantibodies against platelet glycoprotein IIb/IIIa from patients with autoimmune thrombocytopenic purpura may recognize different antigenic determinants
1998
Antibodies against platelet glycoproteins and antiphospholipid antibodies in autoimmune thrombocytopenia
1998
Effect of high-dose intravenous immunoglobulin therapy on blood rheology
1992
International study to compare antigen‐specific methods used for the measurement of antiplatelet autoantibodies
1997
Autoantibodies in chronic ITP
1989
Autoantibodies to platelet glycoproteins in patients with disease‐related immune thrombocytopenia
1989
ADIPOSE TISSUE CELLULARITY IN MATURITY ONSET DIABETES MELLITUS
1972
Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP
1987
Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP
1987
Epidemiology of obesity and hypertension.
1981
Insulin Secretion in Relation to Adipose Tissue in Men
1971
The “metabolically-obese,” normal-weight individual
1981
Acromegaly
1994
Autoantibodies against platelet glycoproteins in autoimmune thrombocytopenic purpura: their clinical significance and response to treatment
1993
Blood amino acid levels in patients with insulin excess (functioning insulinoma) and insulin deficiency (diabetic ketosis)
1978
Cardiovascular risk factors and HDL-cholesterol levels in obesity.
1981
Therapy of chronic idiopathic thrombocytopenic purpura in adults [see comments]
1989
Inhibition of autoantibody binding to platelet glycoprotein IIb/IIIa by anti-idiotypic antibodies in intravenous gammaglobulin
1989
The Glucose Uptake of Human Adipose Tissue in Obesity
1971
Cardiovascular risk factors in gross obesity.
1977
The effects of theα-glucosidase inhibitor BAY g 5421 (Acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man
1979
Inhibition of autoantibody binding to platelet glycoprotein IIb/IIIa by anti-idiotypic antibodies in intravenous gammaglobulin
1989
Obesity-associated disorders in normal-weight individuals: some speculations.
1982
Therapy of chronic idiopathic thrombocytopenic purpura in adults [see comments]
1989
Autoantibodies against platelet membrane glycoproteins in children with acute and chronic immune thrombocytopenic purpura
1989
Absorption Kinetics and Biologic Effects of Subcutaneously Injected Insulin Preparations
1982
Effect of physical training on glucose tolerance and on glucose metabolism of skeletal muscle in anaesthetized normal rats
1979
Obesity and hypertension: cardiovascular response of weight reduction.
1982
Autoantibodies against platelet membrane glycoproteins in children with acute and chronic immune thrombocytopenic purpura
1989
EFFECTS OF PHYSICAL TRAINING ON GLUCOSE TOLERANCE, PLASMA INSULIN AND LIPIDS AND ON BODY COMPOSITION IN MEN AFTER MYOCARDIAL INFARCTION
1972
GLUCOSE TOLERANCE, PLASMA INSULIN AND LIPIDS IN RELATION TO ADIPOSE TISSUE CELLULARITY IN MEN AFTER MYOCARDIAL INFARCTION
1972
Autoantibodies against platelet glycoproteins in autoimmune thrombocytopenic purpura: their clinical significance and response to treatment
1993
Metabolic and hormonal effects of muscular exercise in juvenile type diabetics
1977